CompletedNCT06636227
Different diclofenac doses studied for alcohol use
About this title
Read the official source — NCT06636227Medication studyAges 21–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
- Listed locations
- CatonsvilleSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: December 1, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 23
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT06636227
- Official title
Show the full official title
Optimal Dosing, Tolerability, and Initial Efficacy of Diclofenac as a KMO Inhibitor in Individuals With Alcohol Use Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Catonsville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Maryland, Baltimore, a university.
Did this study involve medication?
Yes. The study involved medication, including Diclofenac 100mg, Diclofenac 75mg, Diclofenac 50mg and Placebo control.
Who was this study for?
Listed age limits: 21 years to 65 years.
